Article
What the FDA flagged
AHA News on Sept. 8 summarized a batch of the FDA’s most serious recalls, early alerts and corrections. Two stand out for hospital leaders.
- Infant heated wire breathing circuits. Medline is removing Hudson RCI neonatal and infant heated wire breathing circuits, covering 18 item numbers and all lots. The company received reports of connectors at the humidifier showing discoloration, melting, smoke or a burning smell. The humidifier cuts power to the heated wires when it senses a fault and gas keeps flowing, but infants may then receive poorly heated gas or extra condensation, with risks that include airway injury, obstruction and cold stress. Medline reported no serious injuries or deaths as of July 31. Products made before January 2024 carry a Teleflex label.
- Spinal cord stimulator leads. Boston Scientific is removing all unused Infinion CX lead kits because stress at the anchor site can cause high impedance or lead fractures, which may require removal and replacement. As of May 27, the company had reported 1,081 serious injuries and no deaths. Implanted leads are not part of the action, and no extra patient monitoring beyond routine follow-up is recommended.
The same roundup listed reprocessed electrophysiology and ultrasound catheters, a neonatal resuscitation hose, convenience kits and two injectable products. It followed an Aug. 28 batch that included saline lots with particulate matter and kits containing recalled components.
Why timing matters
The infant circuit recall shows how long the path can be. Medline wrote to customers on July 13, July 27 and Aug. 5. The FDA issued an early alert on Aug. 21 and updated the notice on Sept. 1. Hospitals that wait for a federal classification before acting may leave affected product on shelves for weeks. The labeling change also means staff searching only by the current brand name could miss older stock.
What a strong process looks like
- One intake point. Route manufacturer letters, FDA notices and supplier alerts to a single team that logs and assigns each one.
- Item-level search. Use item and lot numbers, including legacy labels, across central supply, procedural areas and kits.
- Clinical review. Have clinical leaders decide quickly on substitutes and any patient follow-up.
- Closure tracking. Confirm that quarantine, return or destruction, and response forms are complete.
Archive entry for Sep 9, 2026, added Nov. 11, 2026.
Sources
- FDA issues highest recall for certain breathing circuits, catheters, spinal cord stimulators (AHA News, Sep 8, 2026)
- Breathing circuit recall: Medline removes neonatal and infant heated wire breathing circuits (FDA, Sep 1, 2026)
- Spinal cord stimulator recall: Boston Scientific removes Infinion CX lead (FDA, Sep 3, 2026)
- FDA issues recall, alerts for certain convenience kits; companies voluntarily recall certain IV fluids (AHA News, Aug 28, 2026)